CLX Medical, Inc. Announces Selection of Laboratory for Pre-Clinical Trials Validation Study on Zonda, Inc.'s Rapid Point of Care Test for Chlamydia

Published: Apr 22, 2008

MURRIETA, CA--(Marketwire - April 22, 2008) - CLX Medical, Inc. (OTCBB: CLXN), which owns 51% of Zonda, Incorporated, a developer and manufacturer of unique diagnostic tests for the medical and non-medical markets, today announced that the company has selected IIT Research Institute (IITRI) ( to serve as the laboratory that will conduct a validation study for Zonda's rapid point of care test for chlamydia.

Back to news